MM603Homo sapiens (Human)Cancer cell line
Also known as: MM 603
🤖 AI SummaryBased on 3 publications
Quick Overview
MM603 is a melanoma cell line with BRAF mutation, used in cancer research.
Detailed Summary
MM603 is a melanoma cell line derived from human tissue, characterized by a BRAF mutation (V599E). It is utilized in research to study the molecular mechanisms of melanoma, particularly focusing on BRAF mutation-associated gene expression signatures. The cell line has been analyzed for loss of heterozygosity (LOH) and copy number changes, revealing frequent alterations on chromosome arms 9p, 10p, 10q, 9q, 6q, 11q, and 17p. MM603 has been used in studies involving microarray gene expression profiling and support vector machine (SVM) analysis to identify gene expression patterns linked to BRAF mutations. It is also part of panels used to validate the effectiveness of classifiers for predicting BRAF mutation status in melanoma samples.
Research Applications
BRAF mutation analysisGene expression profilingLoss of heterozygosity (LOH) analysisCopy number variation analysis
Key Characteristics
BRAF mutation (V599E)Frequent LOH on chromosome arms 9p, 10p, 10q, 9q, 6q, 11q, and 17pUsed in SVM-based classification of BRAF mutation status
Generated on 6/19/2025
Basic Information
Database ID | CVCL_2612 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Not specified |
Donor Information
Age Category | Unknown |
---|---|
Sex | Male |
Disease Information
Disease | Melanoma |
---|---|
Lineage | Skin |
Subtype | Melanoma |
OncoTree Code | MEL |
DepMap Information
Source Type | CellBank Australia |
---|---|
Source ID | ACH-001976_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | BRAF | p.Val600Glu (c.1799T>A) | Unspecified | - | PubMed=26214590 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X,Y
CSF1PO
11
D13S317
11,12
D16S539
15
D18S51
12,13
D19S433
14
D21S11
29,30
D2S1338
17,19
D3S1358
14,15
D5S818
12,13
D7S820
11
D8S1179
12,17
FGA
20,23
TH01
8,9.3
TPOX
8,9
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Confirmation of a BRAF mutation-associated gene expression signature in melanoma.
Johansson P., Pavey S., Hayward N.K.
Pigment Cell Res. 20:216-221(2007).
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Stark M.S., Hayward N.K.
Cancer Res. 67:2632-2642(2007).
Microarray expression profiling in melanoma reveals a BRAF mutation signature.
Meltzer P.S., Ringner M., Hayward N.K.
Oncogene 23:4060-4067(2004).
CDKN2A/p16 is inactivated in most melanoma cell lines.";
Gabrielli B.G., Parsons P.G., Hayward N.K.
Cancer Res. 57:4868-4875(1997).